CVRS stock: buy or sell?
October 28th, 2019
Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures.
Should I buy CVRS stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Following a trading plan helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
None of our preferred buy setups matches with Corindus Vascular Robotics stock situation right now, therefore this is not a suitable entry point.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Corindus Vascular Robotics stock a buy?
Banks and financial institutions post stock ratings everyday.Unfortunately, we couldn't detect any rating for CVRS stock for the last month.
CVRS stock analysis
Corindus Vascular Robotics shares remained stable 0.00% to $4.27 on October.
Corindus Vascular Robotics ended on October at $4.27 and remained stable a tight 0.00%. From a daily perspective, CVRS is in a short term uptrend after plotting its last bottom ($4.25, on September) higher than the previous bottom, and its last top ($4.40, on October) also over the previous top. Now trading in between its last bottom and last top CVRS might consolidate in a plain range, waiting to break out over $4.40 or down under $4.25. On August CVRS price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock.
Corindus Vascular Robotics shares stayed stable 0.00% late October, ending at $4.27.
Corindus Vascular Robotics stock is trading in the range of its last top and last bottom. Loosing would mean breaking the current uptrend. Breakdowns under last bottom are selling point signals for some trading strategies. Since early January when CVRS stock price broke up the SMA40w line, it gained $3.22 (306.67%). Late February, SMA10w and SMA20w crossed up triggering a rise of 190.48%.
CVRS stock price history
CVRS IPO was on August 18th, 2014 at $3.15 per share1. Since then, CVRS stock grew a 35.60%, with an average of 7.10% per year. If you had invested right after CVRS's IPO a $1,000 in CVRS stock in 2014, it would worth $356.00 today.
1: Adjusted price after possible price splits or reverse-splits.
CVRS stock historical price chart
CVRS stock reached 52-week highs on October at $4.40, and all-time highs 2015-06-15 with a price of 4.58.
CVRS stock price targetPredicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we have not detected any price forecast for Corindus Vascular Robotics stock by any trusted analyst.
Financials and fundamental analysis
Earnings date and Earnings per Share, when Corindus Vascular Robotics presented its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will extend this report.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual revenues report draw a superb increase of 11.72% to $10.78 million USD. Aligned with this, its profit margin (compared to sales) climbed to -324.54%, that is $-34.99 million. Corindus Vascular Robotics fiscal year ends in December, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Corindus Vascular Robotics TTM sales up to September 2018 were $10.30 and income $-35.53 million dollars. When comparing this TTM figures with the last reported annuality, we can esteem Corindus Vascular Robotics business evolution since December 2018: Annual turnover up to September, compared to lastest yearly report, depreciated a rough -4.48%. Regarding profit margin, Corindus Vascular Robotics collapsed -20.43% to -324.54%
|2013||$0.90 M||-||$-14.69 M-1639.5%||-|
|2014||$36 M||3,917.86%||$0.00 M0.0%||-100.00%|
|2014||$2.98 M||-91.71%||$-24.54 M-822.7%||0.00%|
|2015||$2.73 M||-8.51%||$-28.76 M-1054.0%||17.20%|
|2016||$2.84 M||4.14%||$-33.08 M-1163.9%||15.00%|
|2017||$9.65 M||239.55%||$-34.12 M-353.6%||3.16%|
|2018||$11 M||11.72%||$-34.99 M-324.5%||2.54%|
|TTM||$10 M||-4.48%||$-35.53 M-345.0%||1.53%|
Quarterly financial resultsCorindus Vascular Robotics reported $2.96 M in sales for 2018-Q3, a 77.66% improvement compared to previous quarter. Reported quarter earnings marked $-7.60 million with a profit margin of -256.76%. Profit margin rocketed a 338.37% compared to previous quarter when profit margin was -595.14%. When comparing revenues to same quarter last year, Corindus Vascular Robotics sales marked an outstanding growth and skyrocketed a 21.98%. Looking back to recent quarterly results, Corindus Vascular Robotics posted 2 positive quarters in a row.
|2017-Q1||$1 M||-||$-9.89 M-1272.8%||-|
|2017-Q2||$2 M||190.86%||$-8.41 M-372.1%||-14.96%|
|2017-Q3||$2 M||7.30%||$-7.85 M-323.8%||-6.62%|
|2017-Q4||$4 M||72.78%||$-7.97 M-190.2%||1.50%|
|2018-Q1||$1 M||-64.56%||$-10.05 M-676.8%||26.08%|
|2018-Q2||$2 M||12.12%||$-9.91 M-595.1%||-1.40%|
|2018-Q3||$3 M||77.66%||$-7.60 M-256.8%||-23.35%|
|2018-Q4||$5 M||57.98%||$-7.44 M-159.1%||-2.11%|
Corindus Vascular Robotics ownershipWhen you are planning to buy a company, it's always worth to have a look its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Corindus Vascular Robotics, of all outstanding shares are owned by its staff.
For a better context understanding, the next table shows ownership data compared to other related companies:
|Market cap||$0.0 M|
|Total shares||0.0 M|
|Float shares||0.0 M|
|- Institutional holdings (%)||0.0%|
|- Insider holdings (%)||0.0%|
|Shares in short selling||0.0%|
|Monday, October 28th, 2019|
|Day range||$4.27 - $4.28|
|Average true range||$0.01|
|50d mov avg||$4.26|
|100d mov avg||$3.65|
|200d mov avg||$2.76|
Corindus Vascular Robotics performanceStocks performance is always measured in comparision to the market or competitors and related stocks in the same industry. For Corindus Vascular Robotics, the comparison is made against .